Publicaciones

Clin Transl Oncol. 2018 Nov;20(11):1467-1473. doi: 10.1007/s12094-018-1880-x. Epub 2018 Apr 25.

• Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group.
Costa Rivas M, Huidobro Vence G, Fírvida Pérez JL, Campos Balea B, García Gonzalez J, Lázaro Quintela M, Caeiro Muñoz M, Taboada Valladares B, Castro Gómez JE, Vázquez Estevez S, Afonso Afonso FJ, Azpitarte Raposeiras C, Amenedo Gancedo M, Casal Rubio J.
(ver)

Cancer Manag Res. 2016 Feb 4;8:11-20. doi: 10.2147/CMAR.S85173. eCollection 2016.

• EGFR testing and clinical management of advanced NSCLC: a Galician Lung Cancer Group study (GGCP 048-10).
Vázquez S, Casal J, Afonso Afonso FJ, Fírvida JL, Santomé L, Barón F, Lázaro M, Pena C, Amenedo M, Abdulkader I, González-Arenas C, Fachal L, Vega A.
(ver)

Anticancer Drugs. 2014 Apr;25(4):368-74.

• Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: review of patient profile.
Vázquez S1, Lázaro M, Fírvida JL, Santomé L, Afonso J, Amenedo M, Casal J; Galician Lung Cancer Group (GGCP).
(ver)

Anticancer Res. 2014 Apr;34(4):1959-66.

• Full-dose cisplatin and oral vinorelbine concomitant with radiotherapy in unresectable stage III non-small cell lung cancer: a multi-center phase II study.
Juan O1, Sánchez-Hernández A, Vázquez S, Casal J, Firvida JL, Aparisi F, Muñoz J, García-Sánchez J, Gironés R, Lázaro M, Giner V.
(ver)

Cancer Chemother Pharmacol. 2014 Mar;73(3):451-7.

• A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.
Casal Rubio J1, Fírvida-Pérez JL, Lázaro-Quintela M, Barón-Duarte FJ, Alonso-Jáudenes G, Santomé L, Afonso-Afonso FJ, Amenedo M, Huidobro G, Campos-Balea B, López-Vázquez MD, Vázquez S.
(ver)

Expert Opin Pharmacother. 2012 Jul;13(10):1389-96.

• First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients.
Leon L1, Vázquez S, Gracia JM, Casal J, Lazaro M, Firvida JL, Amenedo M, Santome L, Macia S.
(ver)

Cancer Chemother Pharmacol. 2009 Jul;64(2):379-84.

• A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma.
Rubio JC1, Vázquez S, Vázquez F, Amenedo M, Fírvida JL, Mel JR, Huidobro G, Alvarez E, Lázaro M, Alonso G, Fernández I; Galician Group of Lung Cancer (GGCP in the Spanish acronym).
(ver)

Anticancer Drugs. 2007 Nov;18(10):1201-6.

• Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 013-02).
Vázquez S1, Huidobro G, Amenedo M, Fírvida JL, León L, Lázaro M, Grande C, Mel JR, Ramos M, Salgado M, Casal J.
(ver)

Anticancer Drugs. 2004 Jun;15(5):489-94.

• Biweekly docetaxel as second-line chemotherapy of patients with advanced non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 006-00).
Vázquez S1, Grande C, Amenedo M, Fírvida JL, Lázaro M, Alonso G, Curiel T, Huidobro G, Mel JR, Ramos M.
(ver)

Lung Cancer. 2003 May;40(2):215-20.

• Gemcitabine, cisplatin and vinorelbine as induction chemotherapy followed by radical therapy in stage III non-small-cell lung cancer: a multicentre study of galician-lung-cancer-group.
León L1, Cueva-Banuelos JF, Huidobro G, Fírvida JL, Amenedo M, Lázaro M, Romero C, Estévez SV, Barón FJ, Grande C, García Mata J, González A, Castellanos J, Gómez A, Caeiro M, Rodríguez MR, Casal J; Galician Lung Cancer Group.
(ver)


Comunicaciones a congresos

SEOM 2017

• Tratamiento del cáncer de pulmón no célula pequeña localmente avanzado con radioterapia y quimioterapia concomitante precoz. Estudio GGCP56/12 del Grupo Gallego de Cáncer de Pulmón (GGCP).
(póster)

2017 ASCO Annual Meeting

• ERCC1 expression in tumor tissue as biomarker of outcomes of oral vinorelbine-cisplatin (oVP) combination in metastatic squamous cell lung cancer (SqLC): A prospective study—GGCP052/12.

• Concurrent Chemoradiation (CChRT) for locally advanced stage III Non-Small Cell Lung Cancer (NSCLC) with Cisplatin and Vinorelbine and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group.
(abstract)

17th ECCO-38th ESMO- 32nd ESTRO European Cancer Congress 2013

• Bevacizumab in combination with cisplatin and docetaxel administered every 2 weeks in patients with advanced non-squamous NSCLC   (abstract)
• Paclitaxel and Irinotecan in Platinum Refractory or Resistant Small Cell Lung Cancer   (póster)

15th World Conference on Lung Cancer 2013

• Concurrent Chemoradiation for stage III NSCLC   (abstract)   (póster)
• Gefitinib efficacy in EGFR mutated NSCLC patients based on type of mutation   (abstract)
• Bevacizumab in combination with cisplatin and docetaxel administered every 2 weeks in patients with advanced non-squamous NSCLC   (abstract)   (póster)
• Observational post-authorization prospective study to characterize the incidence of EGFR positive mutation in advanced or metastatic NSCLC patients and their clinical management in Galicia   (póster)
• A phase II study of cisplatin and oral vinorelbine concomitantly with radiotherapy in locally advanced non-small-cell lung cancer treatment: Eficacy and safety results   (abstract)
• Paclitaxel and Irinotecan in Platinum Refractory or Resistant Small Cell Lung Cancer: a Galician Lung Cancer Group experience   (abstract)

XIV Congreso Nacional de Oncología Médica 2013

• Bevacizumab en combinación con Cisplatino y Docetaxel administrado cada 2 semanas en pacientes con CPNM avanzado y de histología no epidermoide: estudio GGCP047/10   (abstract)
• Combinación de irinotecan y gemcitabina como quimioterapia de segunda línea del carcinoma de pulmón de célula pequeña   (abstract)
• Radioterapia torácica y quimioterapia concomitante precoz como tratamiento del cáncer de pulmón no célula pequeña localmente avanzado   (póster)

2013 ASCO Annual Meeting

• Concurrent chemoradiation with bi-weekly docetaxel and cisplatin and thoracic radiotherapy for stage III NSCLC   (póster)

XIII Congreso Nacional de Oncología Médica 2011

• Eficacia y tolerancia de pemetrexed-cisplatino en carcinoma de pulmón no epidermoide avanzado   (póster)
• Docetaxel-cisplatino quincenal en primera línea en carcinoma epidermoide de pulmón avanzado   (póster)

14th World Conference on Lung Cancer  2011

• Tolerance and efficacy of pemetrexed-cisplatin for advanced non-squamous NSCLC   (póster)
• Biweekly docetaxel-cisplatin in chemonaïve patients with squamous NSCLC   (póster)